Cargando…
Comparison of Blood and Blood Product Transfusion in COVID-19 and Non-COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation for Severe Respiratory Failure
COVID-19 has resulted in an exponential increase in patients with severe respiratory failure requiring extracorporeal membrane oxygenation (ECMO). Patients on ECMO regularly require high volumes of blood and blood products but, so far, there has been no comparison of transfusion requirements between...
Autores principales: | Fernando, Malindra C., Hayes, Tim, Besser, Martin, Falter, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381132/ https://www.ncbi.nlm.nih.gov/pubmed/37510781 http://dx.doi.org/10.3390/jcm12144667 |
Ejemplares similares
-
CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH COVID-19 WITH RESPIRATORY FAILURE REQUIRING EXTRACORPOREAL MEMBRANE OXYGENATION
por: Fouad, Jan, et al.
Publicado: (2020) -
Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
por: Aston, Daniel, et al.
Publicado: (2022) -
Extracorporeal membrane oxygenation in the treatment of respiratory failure during COVID‑19
por: Ge, Junbo
Publicado: (2020) -
Venovenous extracorporeal membrane oxygenation in patients with COVID-19 respiratory failure
por: Hayanga, J. W. Awori, et al.
Publicado: (2023) -
Blood Transfusion Strategies in Patients Undergoing Extracorporeal Membrane Oxygenation
por: Kim, Hyoung Soo, et al.
Publicado: (2017)